Children: Population Not at Risk

October 2, 2021

A team of international researchers showing evidence that covid-19 deaths are negligible in children questions the resolution to inoculate them, and asks, “Why are we vaccinating children against covid-19?”

A brand new paper from a team of international scientists entitled, “Why are we vaccinating children against covid-19?” shows evidence that covid-19 deaths are negligible in children, and questions the resolution to inoculate them, as well as mass inoculation for all age groups.

New research, published in the journal “Toxicology Report”, examines issues related to covid-19 deaths in children, and shows that bulk of covid-19 per capita deaths occur in elderly with high comorbidities whereas per capita covid-19 deaths are negligible in children. Authors write that it “appears to be modest benefit from the inoculations to the elderly population most at risk, no benefit to the younger population not at risk, and much potential for harm from the inoculations to both populations. It is unclear why this mass inoculation for all groups is being done, being allowed, and being promoted.”

“The people with myriad comorbidities in the age range”, they explain, “where most deaths with covid-19 occurred were in very poor health. Their deaths did not seem to increase all-cause mortality as shown in several studies. If they hadn’t died with covid-19, they probably would have died from the flu or many of the other comorbidities they had. We can’t say for sure that many/most died from covid-19 because of: 1) how the PCR tests were manipulated to give copious false positives and 2) how deaths were arbitrarily attributed to covid-19 in the presence of myriad comorbidities.”

“Clinical trials for these inoculations were very short-term (a few months), had samples not representative of the total population, and for adolescents/children, had poor predictive power because of their small size. Further, the clinical trials did not address changes in biomarkers that could serve as early warning indicators of elevated predisposition to serious diseases. Most importantly, the clinical trials did not address long-term effects that, if serious, would be borne by children/adolescents for potentially decades.”

“A novel best-case scenario cost-benefit analysis showed very conservatively that there are five times the number of deaths attributable to each inoculation vs those attributable to covid-19 in the most vulnerable 65+ demographic. The risk of death from covid-19 decreases drastically as age decreases, and the longer-term effects of the inoculations on lower age groups will increase their risk-benefit ratio, perhaps substantially.”

“Two issues arise from these results:”

“First, where is the data justifying inoculation for children, much less most people under forty? … What is the rush for a group at essentially zero risks? Given that the inoculations were tested only for a few months, only very short-term adverse effects could be obtained. … A number of researchers have suggested the possibility of severe longer-term autoimmune, Antibody-Dependent Enhancement (ADE), neurological, and other potentially serious effects, with lag periods ranging from months to years. If such effects do turn out to be real, the children are the ones who will have to bear the brunt of the suffering. There appear to be no benefits for the children and young adults from the inoculations and only Costs!”

“The second issue is why the deaths shown … were not predicted by the clinical trials. We examined … trial results (based on a few months of testing) and did not see how (potentially) hundreds of thousands of deaths could have been predicted from the trials’ mortality results. Why this gap?”

“It is becoming clear”, they continue, “that the central ingredient of the injection, the recipe for the spike protein, will produce a product that can have three effects. Two of the three occur with the production of antibodies to the spike protein. These antibodies could allegedly offer protection against the virus (although with all the “breakthrough” cases reported, that is questionable), or could suppress serious symptoms to some extent. They could also cross-react with human tissue antigen, leading to potential autoimmune effects.”

“The third occurs when the injected material enters the bloodstream and circulates widely, which is enabled by the highly vascular injection site and the use of the PEG-2000 coating. This allows spike protein to be manufactured/expressed in endothelial cells at any location in the body, both activating platelets to cause clotting and causing vascular damage. It is difficult to believe this effect is unknown to the manufacturer, and in any case, has been demonstrated in myriad locations in the body using VAERS data. There appears to be modest benefit from the inoculations to the elderly population most at risk, no benefit to the younger population not at risk, and much potential for harm from the inoculations to both populations. It is unclear why this mass inoculation for all groups is being done, being allowed, and being promoted.”

Authors conclude: “Now the objective is the inoculation of the total USA population. Since many of these potential serious adverse effects have built-in lag times of at least six months or more, we won’t know what they are until most of the population has been inoculated, and corrective action may be too late.”

Full Study “Why are we vaccinating children against covid-19?